Abstract
The total health care expenditure as a percentage of the gross domestic product in Sweden is 9.2%, and health care is funded by global budgets almost entirely through general taxation. The prevalence rate of end-stage renal disease (ESRD) in Sweden is 756 per million. Fifty-two percent of ESRD patients have a functioning transplant. Almost all ESRD treatment facilities are public. Compared with other Dialysis Outcomes and Practice Patterns Study (DOPPS) countries, the salaries for both nephrologists and professional dialysis unit staff are low. Sweden’s high cost per ESRD patient, relative to other DOPPS countries, may be a result of expensive and frequent hospitalizations and aggressive anemia treatment strategies.
Similar content being viewed by others
References
Ashton, T., & Marshall, M. R. (2007). The organization and financing of dialysis and kidney transplantation services in New Zealand. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9023-x
Cass A., Chadban S., Craig J., Howard K., McDonald S., Salkeld G., White S. (2006). The economic impact of end stagekidney disease in Australia. Sydney, The George Institute for International Health
Dor, A., Pauly, M. V., Eichleay, M. A., & Held, P. J. (2007). End-stage renal disease and econimic incentives: The International Study of Health Care Organization and Financing (ISHCOF). International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9024-9
Durand-Zaleski, I., Combe, C., & Lang, P. (2007). International Study of Health Care Organization and Financing for end-stage renal disease in France. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9025-8
Hirth, R. A. (2007). The organization and financing of dialysis and kidney transplant care in the United States of America. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9019-6
Jacobson, S. H., Czekalski, S., Hannedouche, T., Loureiro, A., Martin-Malo, A., Papadimitriou, M., Ronco, C., Vanholder, R., Wizemann, V., & Locatelli, F. (2004). Modifiable cardiovascular risk factors: Baseline results of the MPO Study. Journal of the American Society of Nephrology, 15, 614A.
Kjellstrand C., Moody H. (1994). Hemodialysis in Canada: A first-class medical crisis. Canadian Medical Association Journal 150: 1067–1071
Kjellstrand C. (1996). High-technology medicine and the old: The dialysis example. Journal of Internal Medicine 239: 195–210
Kleophas, W., & Reichel, H. (2007). International Study of Health Care Organization and Financing: Development of renal replacement therapy in Germany. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9020-0
Lee H., Manns B.J., Taub K., Ghali W., Dean S., Johnson D., Donaldson C. (2002). Cost analysis of ongoing care of patients with end stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases 40(3): 611–622
Locatelli, F., Hannedouche, T., Jacobson, S. H., La Greca, G., Loureiro, A., Martin-Malo, A., Papadimitriou, M., Vanholder, R., & the MPO Study Group. (2002). Risk factors for cardiovascular diseases in patients starting dialysis in northern and southern Europe: Results from the MPO Study. Nephrology Dialysis Transplantation, 17, 11. Retrieved March 29, 2007 at http://www.abstracts2view.com/era/
Luño, J. (2007). The organization and financing of end-stage renal disease in Spain. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9021-z
Nicholson, T., & Roderick, P. (2007). International Study of Health Care Organization and Financing of Renal Services in England and Wales. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9015-x
Organisation for Economic Co-operation and Development (OECD). (2004). Total expenditure for in-patient care. OECD Health Data 2004 (1st edn). Version 06/07/2004. Paris: Organization for Economic Cooperation and Development.
OECD. (2005). OECD in figures—2005 edition: Health spending and resources. Paris: Organization for Economic Cooperation and Development.
OECD. (2006). Purchasing power parities (PPPs) for OECD countries 1980–2005. Retrieved October 14, 2006, from http://www.oecd.org/statisticsdata/0,2643,en_2649_34357_1_119656_1_1_1,00.html.
Pisoni R.L., Bragg-Gresham J.L., Young E.W., Akizawa T., Asano Y., Locatelli F., Bommer J., Cruz J.M., Kerr P.G., Mendelssohn D. C., Held P.J., Port F.K. (2004). Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases 44(1): 94–111
Pontoriero, G., Pozzoni, P., Del Vecchio, L., & Locatelli, F. (2007). International Study of Health Care Organization and Financing of renal replacement therapy in Italy: An evolving reality.International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9016-9
Rayner H., Pisoni R.L., Bommer J., Canaud B., Hecking E., Locatelli F., Piera L., Bragg-Gresham J.L., Feldman H.I., Goodkin D.A., Gillespie B., Wolfe R.A., Held P.J., Port F.K. (2004). Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis and Transplantation 19: 108–120
Scandiatransplant (2003). Scandiatransplant organ procurement and transplant activity 2003. Retrieved February 19, 2007, from http://www.scandiatransplant.org/tx_newsletter2003.htm.
Statistiska centralbyrån (SCB) (2003). Sveriges officiella statistik: Statistiska meddelanden. Retreived February 26, 2007, from www.scb.se/Statistik/OE/OE0101/2003M00/OE18SM0301.pdf
Svenskt Register för Aktiv Uremivård (SRAU) (2003). Aktiv uremivård i sverige: 1991–2002. Retrieved February 19, 2007, from http://www.socialstyrelsen.se/NR/rdonlyres/AC1A8C40-F4B8-4297-A24B-E7671B8CC31E/0/kva023r03.pdf
U.S. Renal Data System (USRDS) (2005). United States Renal Data System 2005 annual data report: Atlas of end-stage renal disease in the United States.Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Van Biesen, W., Lameire, N., Peeters, P., & Vanholder, R. (2007). Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease. International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9013-z
World Bank (2005). 2005 World Development Indicators. Washington DC: The World Bank Group.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wikström, B., Fored, M., Eichleay, M.A. et al. The financing and organization of medical care for patients with end-stage renal disease in Sweden. Int J Health Care Finance Econ 7, 269–281 (2007). https://doi.org/10.1007/s10754-007-9014-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10754-007-9014-y
Keywords
- End-stage kidney disease
- Health care costs
- Economics
- Renal replacement therapy
- Dialysis
- Reimbursement
- Sweden